In 2024, global private equity and venture capital transaction value and volume in biotechnology declined to their lowest ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at where Galapagos NV (NASDAQ:GLPG) stands against the other cheap biotech ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at where Entrada Therapeutics, Inc. (NASDAQ:TRDA) stands against the other ...

Moleculin Biotech (NASDAQ:MBRX – Get Free Report) was downgraded by stock analysts at Maxim Group from a “buy” rating to a “hold” rating in a report issued on Wednesday, MarketBeat reports.

Moleculin Biotech stock surged on high volume after FDA guidance allowed a 10% reduction in its Phase 3 trial for Annamycin. The MIRACLE Phase 3 study's first unblinding at 45 subjects is expected ...

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

Feb. 12, 2025 (GLOBE NEWSWIRE) -- Portage Biotech, Inc. (“Portage” or the ... it received notification from The Nasdaq Stock Market, LLC (“Nasdaq”) that Nasdaq has accepted Portage ...

The increase will result in a quarterly dividend of $0.79 per share of common stock. Gilead currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank ...

It was a busy week for the biotech sector, as the fourth-quarter earnings season is in full swing. While Gilead Sciences, Inc ...

On Thursday, Moleculin Biotech, Inc., (NASDAQ:MBRX) stock is surging with a strong session volume of 64.85 million compared to an average volume of 157.048K, as per data from Benzinga Pro. The company ...

In this article, we are going to take a look at where Legend Biotech Corporation (NASDAQ ... can outperform the market by imitating the top stock picks of the best hedge funds.